Excess mortality due to pandrug-resistant Acinetobacter baumannii infections in hospitalized patients

2020/09/11 by Stamatis Karakonstantis, S. Karakonstantis, A. Gikas +5 · 5 citations
Biochemistry, Genetics and Molecular Biology · Immunology and Microbiology · Medicine · #Antibiotic Resistance in Bacteria #Antibiotic Use and Resistance #Nosocomial Infections in ICU

paper · doi:10.1016/j.jhin.2020.09.009

openalex publication_date 2020/09/11 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/28

Cited by

• In-hospital mortality from healthcare-associated infection by multidrug-resistant Pseudomonas aeruginosa: a competing risks analysis of a 4-year propensity-matched cohort study in southern China
• Cefiderocol (CFDC): A Spy Antibiotic Future Replacement of Carbapenem
• The intracellular life of Acinetobacter baumannii
• Deep learning reveals antibiotics in the archaeal proteome
• Risk factors for infection after carbapenem-resistant Acinetobacter baumannii colonization